Japanese journal of clinical oncology
Association between bevacizumab administration and delayed wound healing complications before and after central venous port placement in patients with colorectal cancer.
Kohei Takura, Miyuki Sone, Hidekazu Hirano, Ken Kato, Sho Murakami, Tomoya Tanishima, Rakuhei Nakama, Mizuki Ozawa, Takumi Oshima, Shintaro Kimura, Chihiro Itou, Shunsuke Sugawara, Yoshiyuki Matsui, Yukihide Kanemitsu, Masahiko Kusumoto
Published: 202610.1093/jjco/hyag006
Abstract
BACKGROUND: Bevacizumab (BEV) is commonly used to treat unresectable or metastatic colorectal cancer; however, it is associated with delayed wound healing. This study aimed to assess whether administration of BEV within 14 days after central venous (…
Preview only. Read the full abstract at the source